Indianapolis-based Trimedx names new CEO
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
The former CEO of a health care technology company acquired by UnitedHealth Group in a multibillion-dollar deal has been named the new leader of medical device management and cybersecurity services provider Trimedx.
Neil de Crescenzo assumed the role of CEO for the Indianapolis-based company on Wednesday. He succeeds Henry Hummel, who served as CEO since 2017 and now will become board chair.
“Trimedx has set the standard in clinical asset management, leveraging technology and data-driven insights to enhance patient care and operational efficiency, enabled by a culture of empowerment, caring, innovation, and customer focus,” de Crescenzo said in a news release. “I am excited to be working with our associates on our next phase of innovation and growth, continuing to provide exceptional service to our clients and making a meaningful impact in healthcare.”
Earlier in his career, de Crescenzo held leadership positions at Oracle Corp. and IBM Corp., the release said. More recently he served as CEO of Optum Insight, a provider of health care-related software services and analytics. A division of UnitedHealth Group, Optum in 2022 acquired Change Healthcare for $13 billion. de Crescenzo had served as president and CEO of Change Healthcare.
Hummel led Trimedx through a period of notable growth during his tenure as CEO. The company, which provides services to hospitals and health systems, tripled in size, expanding from about 1,200 employees serving 1,800 locations to more than 3,200 employees supporting nearly 6,000 locations. Trimedx acquired Aramark’s health care technologies business and Centurion Service Group, a provider of surplus medical equipment management.
Hummel also spearheaded technology and medical-device cybersecurity advancements, and the company received a number of honors recognizing its workplace culture.
“I am incredibly proud of what we have accomplished at Trimedx,” Hummel said. “I have full confidence that under Neil’s leadership, Trimedx will continue to thrive, driving forward new advancements in clinical asset management and making a lasting impact on the industry.”